Faruqi & Faruqi, LLP is investigating claims against Grail, Inc. following the company's announcement that its NHS-Galleri cancer screening trial did not meet its primary endpoint of significantly reducing late-stage cancers. The trial results revealed on February 19, 2026, led to a sharp 50% drop in Grail's stock price. The law firm reminds investors who bought Grail shares between May 13, 2025, and February 19, 2026, of the August 4, 2026 deadline to seek lead plaintiff status in the class action lawsuit. Investors are encouraged to contact the firm to discuss their legal options and potential recovery.
Recent financial reports show strong earnings beats driven by surging demand for artificial intelligence (AI) technologies, with companies like ServiceTitan, Palo Alto Networks, and CrowdStrike exceeding revenue and earnings estimates. Policymakers i...
The Procure Space ETF (UFO) has surged 138.53% over the past year and 53.53% year to date, fueled by a diversified portfolio of satellite operators and related infrastructure. Its broad-based holdings across satellite communications, launch services,...
The rapid expansion of AI technology is driving unprecedented demand for energy and infrastructure, with hyperscale data centers consuming vast amounts of electricity and water. This surge is causing bottlenecks in transformer manufacturing, grid cap...
Direxion Daily Technology Bull 3X Shares (TECL) fell 19.93% on June 5, reflecting a 6.66% drop in its underlying index, the Technology Select Sector SPDR Fund (XLK). The sharp decline was driven by disappointing guidance from Broadcom and rising inte...
Pudgy Penguins has achieved a major milestone by placing its Pudgy Toys in 3,100 Walmart and Target stores, marking a rare retail success for a blockchain-based brand. Parent company Igloo raised $11 million in 2024, led by Founders Fund, signaling s...
